megestrol acetate has been researched along with fadrozole in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chinchilli, VM; Demers, L; Grossberg, H; Harvey, H; Konrad, K; Leitzel, K; Lipton, A; Teramoto, Y; Volas, G | 1 |
| Demers, L; Grossberg, H; Leitzel, K; Lipton, A; Teramoto, Y; Volas, GH | 1 |
| Buzdar, AU; Hortobagyi, GN; Plourde, PV | 1 |
| Buzdar, AU | 1 |
| Ali, SM; Allard, JW; Carney, W; Chinchilli, VM; Demers, L; Engle, L; Harvey, HA; Leitzel, K; Lipton, A | 1 |
| Ali, SM; Brown-Shimer, S; Carney, W; Demers, L; Evans, DB; Hamer, P; Leitzel, K; Lipton, A; Pierce, K | 1 |
| Ali, SM; Demers, L; Evans, DB; Evans, M; Leitzel, K; Lipton, A; Vo, MN; Wilson, M | 1 |
1 review(s) available for megestrol acetate and fadrozole
| Article | Year |
|---|---|
A summary of second-line randomized studies of aromatase inhibitors.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Drug Tolerance; Enzyme Inhibitors; Estrogen Receptor Modulators; Fadrozole; Female; Humans; Letrozole; Megestrol Acetate; Neoplasms, Hormone-Dependent; Nitriles; Randomized Controlled Trials as Topic; Tamoxifen; Triazoles | 2001 |
5 trial(s) available for megestrol acetate and fadrozole
| Article | Year |
|---|---|
Elevated serum c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antigens; Breast Neoplasms; Chi-Square Distribution; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Gene Amplification; Humans; Megestrol; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Regression Analysis; Survival Analysis; Tamoxifen; Treatment Outcome | 1995 |
Serial serum c-erbB-2 levels in patients with breast carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; Carcinoma; Disease Progression; Double-Blind Method; Enzyme Inhibitors; Fadrozole; Female; Humans; Megestrol; Megestrol Acetate; Placebos; Prognosis; Receptor, ErbB-2; Remission Induction; Treatment Outcome | 1996 |
Relationship of serum HER-2/neu and serum CA 15-3 in patients with metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Mucin-1; Neoplasm Metastasis; Prognosis; Receptor, ErbB-2; Retrospective Studies | 2002 |
Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Disease Progression; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Humans; Megestrol Acetate; Middle Aged; Prognosis; Receptor, ErbB-2; Survival Rate; Tissue Inhibitor of Metalloproteinase-1 | 2007 |
Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy.
Topics: Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast Neoplasms; Double-Blind Method; Drug Resistance, Neoplasm; Endoglin; Enzyme-Linked Immunosorbent Assay; Fadrozole; Female; Humans; Kaplan-Meier Estimate; Megestrol Acetate; Middle Aged; Receptors, Cell Surface | 2010 |
1 other study(ies) available for megestrol acetate and fadrozole
| Article | Year |
|---|---|
Aromatase inhibitors in metastatic breast cancer.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Megestrol Acetate; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Nitriles; Tamoxifen; Triazoles | 1996 |